To update the causal estimates for the effects of adult body mass index (BMI), childhood BMI, and vitamin D status on multiple sclerosis (MS) risk.
We used 2-sample Mendelian randomization to determine causal estimates. Summary statistics for SNP associations with traits of interest were obtained from the relevant consortia. Primary analyses consisted of random-effects inverse-variance-weighted meta-analysis, followed by secondary sensitivity analyses.
Genetically determined increased childhood BMI (OR MS 1.24, 95% CI 1.05–1.45, p = 0.011) and adult BMI (OR MS 1.14, 95% CI 1.01–1.30, p = 0.042) were associated with increased MS risk. The effect of genetically determined adult BMI on MS risk lessened after exclusion of 16 variants associated with childhood BMI (OR MS 1.11, 95% CI 0.97–1.28, p = 0.121). Correcting for effects of serum vitamin D in a multivariate analysis did not alter the direction or significance of these estimates. Each genetically determined unit increase in the natural-log-transformed vitamin D level was associated with a 43% decrease in the odds of MS (OR 0.57, 95% CI 0.41–0.81, p = 0.001).
(1) AbbVie, (2)Actelion, (3) Biogen, (4) Celgene, (5)Sanofi-Genzyme, (6) Genentech, (7) GlaxoSmithKline, (8) Merck-Serono, (9) Novartis, (10) Roche and (11) Teva.
Speaker honoraria: (1) AbbVie, (2) Actelion, (3) Biogen, (4) Celgene, (5) Sanofi-Genzyme, (6) Genentech, (7) Merck-Serono, (8) Novartis, (9) Roche and (10) Teva.
(1) AbbVie, (2) Actelion, (3) Atara Bio, (4) Biogen, (5) Celgene, (6) Sanofi-Genzyme, (7) Genentech, (8) GlaxoSmithKline, (9) Merck-Serono, (10) Novartis, (11) Roche and (12) Teva.
(1) Biogen Idec, speaker honoraria (2) Teva, speaker honoraria (3) Neurology Academy, speaker honoraria (4) Sanofi Genzyme, attendance at educational meeting (5) Northern Connections MS meeting, speaker honoraria
(1) I am currently funded by a grant from Barts Charity (2) Current funding from MS Society of Great Britain and Northern Ireland (3) Current funding from Horne Family Trust (4) MS Society of Great Britain and Northern Ireland/Association of British Neurologists funded my previous position as a Clinical Research Fellow
Go to Neurology.org/NN for full disclosures. Funding information is provided at the end of the article.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.